medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2010, Number 3

<< Back Next >>

Rev Invest Clin 2010; 62 (3)

Osteoartropatía hipertrófica: Linaje, orígenes y textura

Martínez-Lavín M, Pineda VC

Language: Spanish
References: 29
Page: 261-266
PDF size: 55.03 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Martínez-Lavín M, Matucci-Cerinic M, Jajic I, Pineda C. Hypertrophic osteoarthropathy: Consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol 1993; 20: 1386-7.

  2. Marie P. De l’ostéo-arthropathie hypertrophiante pneumique Rev Med 1890; 10: 1-36.

  3. Martinez-Lavin M. Hypertrophic osteoarthropathy. 4th. Ed. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds.). Rheumatology. Edinburg: Mosby; 2007.

  4. Martínez-Lavín M, Mansilla J, Pineda C, Pijoán C, Ochoa P. Evidence of hypertrophic osteoarthropathy in human skeletal remains from prehispanic Mesoamerica. Ann Intern Med 1994; 120: 238-41.

  5. Martínez-Lavín M, Pineda C, Valdez T, Cajigas JC, Weisman M. Primary hypertrophic osteoarthropathy. Sem Arthritis Rheum 1988; 17: 156-62.

  6. Martínez-Lavín M, Bobadilla M, Casanova J, Attié F, Martínez M. Hypertrophic osteoarthropathy in cyanotic heart disease: Its prevalence and relationship to bypass of the lung. Arthritis Rheum 1982; 25: 1186-93.

  7. Currie AE, Gallagher PJ. The pathology of clubbing: Vascular changes in the nail bed. Br J Dis Chest 1988; 82: 382-5.

  8. Martinez-Lavin M. Exploring the cause of the oldest clinical sign of medicine; finger clubbing. Semin Arthritis Rheum 2007; 36: 380-5.

  9. Martínez-Lavín M. Digital clubbing and hypertrophic osteoarthropathy: A unifying hypothesis. J Rheumatol 1987; 14: 6-8.

  10. Dickinson C, Martin J. Megakaryocyte and platelet clumps as cause of finger clubbing. Lancet 1987; 11: 1434-5.

  11. Matucci-Cerinic M, Martínez-Lavín M, Rojo F, Fonseca C, Kahaleh B. von Willebrand factor in hypertrophic osteoarthropathy. J Rheumatol 1992; 19: 765-7.

  12. Vazquez-Abad D, Martínez-Lavín M. Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1991; 9: 59-62.

  13. Fonseca C, Martínez-Lavín M, Hernandez-Rodriguez N, Osornio- Vargas A. Circulating plasma levels of platelet-derived growth factor in patients with hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992; 10(Suppl. 7): 73.

  14. Martínez-Lavín M, Vargas AS, Cabré J, Nava A, Silveira LH, Amigo MC, Pineda C. Features oh hypertrophic osteoarthropathy in patients with POEMS syndrome: A metaanalysis. J Rheumatol 1997; 24: 2267-8.

  15. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I, Authier FJ, Gherardi RK. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996; 347: 702.

  16. Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, Piette JC, Chapman A. Growth factors in POEMS syndrome: Evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997; 40: 786-7.

  17. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.

  18. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.

  19. Silveira LH, Martínez-Lavín M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000; 18: 57-62.

  20. Silveira LH, Martínez-Lavín M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000; 18: 57-62.

  21. Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 2004; 203: 721-8.

  22. Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bielenska A, Phillips SE, Markham AF, Bennett CP, Brnthron DT. Muations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008; 40: 789-93.

  23. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93: 2490-6.

  24. Pineda C, Weisman M, Guerra A, Resnick D, Martínez-Lavín M. The skeletal manifestations of clubbing: a study in patients with cyanotic heart disease and hypertrophic osteoarthropathy. Sem Arthritis Rheum 1985; 14: 263-7.

  25. Pineda C, Fonseca C, Martínez-Lavín M. The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropathy. J Rheumatol 1990; 17: 626-32.

  26. Pineda C, Martínez-Lavín M, Goobar J, Sartoris D, Clopton P, Resnick D. Periostitis in hypertrophic osteoarthropathy: Rela tionship to diseases duration. AM J Roentgenol 1987; 148: 773-8.

  27. Pineda C. Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheumatol 1992; 10(Suppl.): 27-34.

  28. Gall E, Bennett GA, Bauer W. Generalized hypertrophic osteoarthropathy: A pathologic study of seven cases. Am J Pathol 1951; 27: 349-81.

  29. Jajiæ Z, Jajiæ I, Nemcic T. Primary hypertrophic osteoarthropathy: Clinical, radiologic, and scintigraphic characteristics. Arch Med Research 2001; 32: 136-42.




2020     |     www.medigraphic.com